RORγ agonist 1 is a potent, orally bioavailable small molecule activator of the RORγ receptor, with an EC50 of 21 nM. It is a valuable research tool for studying Th17 cell biology, autoimmunity, and oncology, demonstrating antitumor activity in both cellular assays and in vivo models.